Terms: = Skin cancer AND PR, PGR, progesterone receptor AND Staging
23 results:
1. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
2. The use of interferon-α2a as monotherapy in stage IB patients with mycosis fungoides: A retrospective chart review of patient outcomes.
Gökşin Ş; İmren IG; Cenk H; Kaçar N; Duygulu Ş
Dermatol Ther; 2022 Apr; 35(4):e15344. PubMed ID: 35094466
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study.
Wang D; Wang P; Li C; Zhou Z; Zhang L; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102670. PubMed ID: 34883272
[TBL] [Abstract] [Full Text] [Related]
4. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years.
Pattamadilok B; Poomputsar T
Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):49-55. PubMed ID: 32964521
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides.
Amorim GM; Corbellini JPN; Quintella DC; Cuzzi T; Ramos-E-Silva M
An Bras Dermatol; 2018; 93(5):680-685. PubMed ID: 30156617
[TBL] [Abstract] [Full Text] [Related]
6. Results of radiotherapy in minimal stage mycosis fungoides: a reappraisal after ten years.
Esposito L; Piccinno R; Marchese L; Berti E
G Ital Dermatol Venereol; 2020 Aug; 155(4):483-486. PubMed ID: 29485254
[TBL] [Abstract] [Full Text] [Related]
7. The Value of Hormone receptor Assessment in Ultrasound Guided Core Needle Biopsy of the Breast.
Pal A; Milevcić D; Bosilj D; Purković S; Cujzek I; Kopjar A; Radiković S
Coll Antropol; 2015 Dec; 39(4):923-5. PubMed ID: 26987161
[TBL] [Abstract] [Full Text] [Related]
8. CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma.
Prince HM
J Clin Oncol; 2015 Nov; 33(32):3691-6. PubMed ID: 26392103
[TBL] [Abstract] [Full Text] [Related]
9. New approaches in the management of male breast cancer.
Patten DK; Sharifi LK; Fazel M
Clin Breast Cancer; 2013 Oct; 13(5):309-14. PubMed ID: 23845572
[TBL] [Abstract] [Full Text] [Related]
10. Isolated cutaneous metastasis of uterine leiomyosarcoma: case report and review of literature.
Corcoran S; Hogan AM; Nemeth T; Bennani F; Sullivan FJ; Khan W; Barry K
Diagn Pathol; 2012 Jul; 7():85. PubMed ID: 22809451
[TBL] [Abstract] [Full Text] [Related]
11. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.
Abramowitz MC; Li T; Morrow M; Sigurdson ER; Anderson P; Nicolaou N; Freedman G
Am J Clin Oncol; 2009 Feb; 32(1):30-3. PubMed ID: 19194121
[TBL] [Abstract] [Full Text] [Related]
12. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology.
Sanki A; Kam PC; Thompson JF
Ann Surg; 2007 Apr; 245(4):591-6. PubMed ID: 17414608
[TBL] [Abstract] [Full Text] [Related]
13. Risk-reducing mastectomy.
Edlich RF; Winters KL; Faulkner BC; Lin KY
J Long Term Eff Med Implants; 2006; 16(4):301-14. PubMed ID: 17073572
[TBL] [Abstract] [Full Text] [Related]
14. Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma.
Dummer R; Garbe C; Thompson JA; Eggermont AM; Yoo K; Maier T; Bergstrom B
J Clin Oncol; 2006 Mar; 24(7):1188-94. PubMed ID: 16505439
[TBL] [Abstract] [Full Text] [Related]
15. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.
Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M
Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205
[TBL] [Abstract] [Full Text] [Related]
16. Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma.
Fink W; Zimpfer-Rechner C; Thoelke A; Figl R; Kaatz M; Ugurel S; Schadendorf D
Onkologie; 2004 Dec; 27(6):540-4. PubMed ID: 15591712
[TBL] [Abstract] [Full Text] [Related]
17. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract] [Full Text] [Related]
18. Factors correlating with lymph node metastases in patients with T1 breast cancer.
Brenin DR; Manasseh DM; El-Tamer M; Troxel A; Schnabel F; Ditkoff BA; Kinne D
Ann Surg Oncol; 2001 Jun; 8(5):432-7. PubMed ID: 11407518
[TBL] [Abstract] [Full Text] [Related]
19. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract] [Full Text] [Related]
20. [Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy].
Seegenschmiedt MH; Keilholz L; Pieritz A; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Strahlenther Onkol; 1999 Sep; 175(9):450-7. PubMed ID: 10518979
[TBL] [Abstract] [Full Text] [Related]
[Next]
